Clinical Trials Logo

Clinical Trial Summary

DOREVI is a monocentric randomized controlled study that will evaluate the efficacy of virtual reality helmets for pain prevention during invasive care on 78 oncologic pediatric patients. Two groups of children (between 6 and 11 and between 12 and 18 years old) will be randomized to use helmet plus standard care or standard care alone during invasive procedures (central venous catheter puncture, lumbar puncture, or bone marrow aspiration). The pain intensity will be evaluated using a visual analogic scale during three invasive procedures, and results will be compared between the patients with or without virtual reality.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05592132
Study type Interventional
Source Centre Hospitalier Universitaire de la Réunion
Contact Yves REGUERRE
Phone +262262905676
Email yves.reguerre@chu-reunion.fr
Status Recruiting
Phase N/A
Start date January 17, 2023
Completion date October 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03728543 - the Efficacy and Safety of Sugammadex in Children 0-2 Years Old Phase 2/Phase 3
Recruiting NCT04471961 - Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia N/A
Not yet recruiting NCT04856020 - Role of Gray Scale and Color Doppler Ultrasound in Diagnosis of Pediatric Neck Masses